Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Preventive Medicine Reports|May 6, 2020
Underuse of statins for secondary prevention of atherosclerotic cardiovascular disease events among ambulatory surgical patientsRobert B Schonberger, Vivek Vallurupalli, Hollie Matlin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 8, 2016
Familial dilated cardiomyopathy diagnosis is commonly overlooked at the time of transplant listingSara B Seidelmann, Olga Laur, John Hwa, et al.
Behavioral Sleep Medicine|October 13, 2020
Day-to-day Relationships between Physical Activity and Sleep Characteristics among People with Heart Failure and InsomniaGarrett Ash, Sangchoon Jeon, Samantha Conley, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 22, 2019
Improving Outcomes in INTERMACS Category 1 Patients with Pre-LVAD, Awake Venous-Arterial Extracorporeal Membrane Oxygenation SupportMakoto Mori, Gerard McCloskey, Arnar Geirsson, et al.
Circulation. Heart Failure|June 6, 2020
Study Design and Rationale of EXPLORER-HCM: Evaluation of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic CardiomyopathyCarolyn Y Ho, Iacopo Olivotto, Daniel Jacoby, et al.
Plos One|February 4, 2016
Clinical Implications of Cluster Analysis-Based Classification of Acute Decompensated Heart Failure and Correlation with Bedside Hemodynamic ProfilesTariq Ahmad, Nihar Desai, Francis Wilson, et al.
Lancet (London, England)|May 18, 2021
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trialJohn A Spertus, Jennifer T Fine, Perry Elliott, et al.
Contemporary Clinical Trials|February 5, 2017
Cognitive behavioral therapy for insomnia in stable heart failure: Protocol for a randomized controlled trialNancy S Redeker, Andrea K Knies, Christopher Hollenbeak, et al.
JAMA Cardiology|November 7, 2019
Association of Obesity With Adverse Long-term Outcomes in Hypertrophic CardiomyopathyCarlo Fumagalli, Niccolò Maurizi, Sharlene M Day, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|December 22, 2021
The integration of genetically-regulated transcriptomics and electronic health records highlights a pattern of medical outcomes related to increased hepatic transthyretin expressionGita A Pathak, Antonella De Lillo, Frank R Wendt, et al.
Pageof 8